Methotrexate vs. Ergocalciferol: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Methotrexate and Ergocalciferol. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 917,852 people who take Methotrexate and Ergocalciferol, and is updated regularly.
What is Methotrexate?
Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,314 Methotrexate users. Check the latest studies of Methotrexate.
What is Ergocalciferol?
Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
917,852 people who take Methotrexate and Ergocalciferol are studied.
Drugs being compared in this study:
- Methotrexate (methotrexate sodium)
- Ergocalciferol (ergocalciferol)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Methotrexate:
- not at all: 6.01 %
- somewhat: 25.98 %
- moderate: 33.91 %
- high: 25.57 %
- very high: 8.54 %
Ergocalciferol:
- not at all: 3.25 %
- somewhat: 20.05 %
- moderate: 36.14 %
- high: 29.92 %
- very high: 10.65 %
Want to compare Methotrexate with Ergocalciferol?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
- Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
Related studies
Alternative drugs to, pros and cons of:
- Methotrexate (599,792 reports)
- Ergocalciferol (32,551 reports)
Browse all side effects of Methotrexate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ergocalciferol:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on methotrexate sodium and ergocalciferol (the active ingredients of Methotrexate and Ergocalciferol, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Septic Shock and Hyperkalemia - now
- Could Claritin-D 24 Hour cause Diarrhea? - now
- Could Claritin-D 24 Hour cause Stools - Watery? - now
- Could Ademetionine cause Diarrhea Aggravated? - now
- Could Budesonide cause Extrapyramidal Disorder? - now
- Atrial Fibrillation/Flutter and Hallucination, Auditory - a second ago
- Could Ritonavir cause Cholestasis? - 8 seconds ago
- Could Clarinex cause Gallstones? - 10 seconds ago
- Could Venofer cause Fainting? - 11 seconds ago
- Could Venofer cause Multi-Organ Failure? - 13 seconds ago